Targeting mucosal dendritic cells with microbial antigens from probiotic lactic acid bacteria

References

• Acheson DW, Luccioli S. Mucosal immune responses. Best Pract. Res. Clin. Gastroenterol.18(2), 387–404 (2004).
   PubMed Web of Science ®Google Scholar
• Niedergang F, Kweon MN. New trends in antigen uptake in the gut mucosa. Trends Microbiol.13(10), 485–490 (2005)
   PubMed Web of Science ®Google Scholar
• Holmgren J, Czerkinsky C. Mucosal immunity and vaccines. Nat. Med.11(4 Suppl.), S45–S53 (2005).
   PubMed Web of Science ®Google Scholar
• Akira S. TLR signaling. Curr. Top. Microbiol. Immunol.311, 1–16 (2006).
   PubMed Web of Science ®Google Scholar
• Akira S, Takeda K, Kaisho T. Toll-like receptors: critical proteins linking innate and acquired immunity. Nat. Immunol.2(8), 675–680 (2001).
   PubMed Web of Science ®Google Scholar
• Ishii KJ, Uematsu S, Akira S. ‘Toll’ gates for future immunotherapy. Curr. Pharm. Des.12(32), 4135–4142 (2006).
   PubMed Web of Science ®Google Scholar
• Kawai T, Akira S. TLR signaling. Semin. Immunol.19(1), 24–32 (2007).
   PubMed Web of Science ®Google Scholar
• Takeda K, Kaisho T, Akira S. Toll-like receptors. Annu. Rev. Immunol.21, 335–376 (2003).
   PubMed Web of Science ®Google Scholar
• Akira S, Takeda K. Toll-like receptor signalling. Nat. Rev. Immunol.4(7), 499–511 (2004).
   PubMed Web of Science ®Google Scholar
• Sierro F, Dubois B, Coste A, Kaiserlian D, Kraehenbuhl JP, Sirard JC. Flagellin stimulation of intestinal epithelial cells triggers CCL20-mediated migration of dendritic cells. Proc. Natl Acad. Sci. USA98(24), 13722–13727 (2001).
   PubMed Web of Science ®Google Scholar
• Iliev ID, Matteoli G, Rescigno M. The yin and yang of intestinal epithelial cells in controlling dendritic cell function. J. Exp. Med.204(10), 2253–2257 (2007).
   PubMed Web of Science ®Google Scholar
• Debard N, Sierro F, Browning J, Kraehenbuhl JP. Effect of mature lymphocytes and lymphotoxin on the development of the follicle-associated epithelium and M cells in mouse Peyer’s patches. Gastroenterology120(5), 1173–1182 (2001).
   PubMed Web of Science ®Google Scholar
• Hathaway LJ, Kraehenbuhl JP. The role of M cells in mucosal immunity. Cell Mol. Life Sci.57(2), 323–332 (2000).
   PubMed Web of Science ®Google Scholar
• Kraehenbuhl JP, Neutra MR. Epithelial M cells: differentiation and function. Annu. Rev. Cell Dev. Biol.16, 301–332 (2000).
   PubMed Web of Science ®Google Scholar
• Neutra MR, Mantis NJ, Kraehenbuhl JP. Collaboration of epithelial cells with organized mucosal lymphoid tissues. Nat. Immunol.2(11), 1004–1009 (2001).
   PubMed Web of Science ®Google Scholar
• Niedergang F, Kraehenbuhl JP. Much ado about M cells. Trends Cell Biol.10(4), 137–141 (2000).
   PubMed Web of Science ®Google Scholar
• Finke D, Kraehenbuhl JP. Formation of Peyer’s patches. Curr. Opin. Genet. Dev.11(5), 561–567 (2001).
   PubMed Web of Science ®Google Scholar
• Gebert A, Pabst R. M cells at locations outside the gut. Semin. Immunol.11(3), 165–170 (1999).
   PubMed Web of Science ®Google Scholar
• Gebert A, Fassbender S, Werner K, Weissferdt A. The development of M cells in Peyer’s patches is restricted to specialized dome-associated crypts. Am. J. Pathol.154(5), 1573–1582 (1999).
   PubMed Web of Science ®Google Scholar
• Gebert A, Steinmetz I, Fassbender S, Wendlandt KH. Antigen transport into Peyer’s patches: increased uptake by constant numbers of M cells. Am. J. Pathol.164(1), 65–72 (2004).
   PubMed Web of Science ®Google Scholar
• Kerneis S, Pringault E. Plasticity of the gastrointestinal epithelium: the M cell paradigm and opportunism of pathogenic microorganisms. Semin. Immunol.11(3), 205–215 (1999).
   PubMed Web of Science ®Google Scholar
• Hamzaoui N, Kerneis S, Caliot E, Pringault E. Expression and distribution of beta1 integrins in in vitro-induced M cells: implications for Yersinia adhesion to Peyer’s patch epithelium. Cell Microbiol.6(9), 817–828 (2004).
   PubMed Web of Science ®Google Scholar
• Jang MH, Kweon MN, Iwatani K et al. Intestinal villous M cells: an antigen entry site in the mucosal epithelium. Proc. Natl Acad. Sci. USA101(16), 6110–6115 (2004).
   PubMed Web of Science ®Google Scholar
• Steinman RM, Banchereau J. Taking dendritic cells into medicine. Nature449(7161), 419–426 (2007).
   PubMed Web of Science ®Google Scholar
• Banchereau J. The long arm of the immune system. Sci. Am.287(5), 52–59 (2002).
   PubMed Web of Science ®Google Scholar
• Banchereau J, Briere F, Caux C et al. Immunobiology of dendritic cells. Annu. Rev. Immunol.18, 767–811 (2000).
   PubMed Web of Science ®Google Scholar
• Banchereau J, Steinman RM. Dendritic cells and the control of immunity. Nature392(6673), 245–252 (1998).
   PubMed Web of Science ®Google Scholar
• Palucka K, Banchereau J. How dendritic cells and microbes interact to elicit or subvert protective immune responses. Curr. Opin. Immunol.14(4), 420–431 (2002).
   PubMed Web of Science ®Google Scholar
• Pulendran B, Palucka K, Banchereau J. Sensing pathogens and tuning immune responses. Science293(5528), 253–256 (2001).
   PubMed Web of Science ®Google Scholar
• Palucka AK, Banchereau J. Langerhans cells: daughters of monocytes. Nat. Immunol.7(3), 223–224 (2006).
   PubMed Web of Science ®Google Scholar
• Wu L, Liu YJ. Development of dendritic-cell lineages. Immunity26(6), 741–750 (2007).
   PubMed Web of Science ®Google Scholar
• Austyn JM. New insights into the mobilization and phagocytic activity of dendritic cells. J. Exp. Med.183(4), 1287–1292 (1996).
   PubMed Web of Science ®Google Scholar
• Austyn JM. Dendritic cells. Curr. Opin. Hematol.5(1), 3–15 (1998).
   PubMedGoogle Scholar
• Sallusto F, Cella M, Danieli C, Lanzavecchia A. Dendritic cells use macropinocytosis and the mannose receptor to concentrate macromolecules in the major histocompatibility complex class II compartment: downregulation by cytokines and bacterial products. J. Exp. Med.82(2), 389–400 (1995).
   Google Scholar
• Lanzavecchia A, Sallusto F. Regulation of T cell immunity by dendritic cells. Cell106(3), 263–266 (2001).
   PubMed Web of Science ®Google Scholar
• Mohamadzadeh M, Pavlidou A, Enk A, Knop J, Rude E, Gradehandt G. Freshly isolated mouse 4F7+ splenic dendritic cells process and present exogenous antigens to T cells. Eur. J. Immunol.24(12), 3170–3174 (1994).
   PubMed Web of Science ®Google Scholar
• Caux C, Vanbervliet B, Massacrier C et al. CD34+ hematopoietic progenitors from human cord blood differentiate along two independent dendritic cell pathways in response to GM-CSF+TNF α. J. Exp. Med.184(2), 695–706 (1996).
   PubMed Web of Science ®Google Scholar
• Mohamadzadeh M, Berard F, Essert G et al. Interleukin 15 skews monocyte differentiation into dendritic cells with features of Langerhans cells. J. Exp. Med.194(7), 1013–1020 (2001).
   PubMed Web of Science ®Google Scholar
• Sallusto F, Lanzavecchia A. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor a. J. Exp. Med.179(4), 1109–1118 (1994).
   PubMed Web of Science ®Google Scholar
• Grouard G, Durand I, Filgueira L, Banchereau J, Liu YJ. Dendritic cells capable of stimulating T cells in germinal centres. Nature384(6607), 364–367 (1996).
   PubMed Web of Science ®Google Scholar
• Liu YJ, Grouard G, de Bouteiller O, Banchereau J. Follicular dendritic cells and germinal centers. Int. Rev. Cytol.66, 139–179 (1996).
   Google Scholar
• Schoenberger SP, Toes RE, van der Voort EI, Offringa R, Melief CJ. T-cell help for cytotoxic T lymphocytes is mediated by CD40-CD40L interactions. Nature393(6684), 480–483 (1998).
   PubMed Web of Science ®Google Scholar
• Kelsoe G, Zheng B. Sites of B-cell activation in vivo. Curr. Opin. Immunol.5(3), 418–422 (1993).
   PubMed Web of Science ®Google Scholar
• Pulendran B, Karvelas M, Nossal GJ. A form of immunologic tolerance through impairment of germinal center development. Proc. Natl Acad. Sci. USA91(7), 2639–2643 (1994).
   PubMed Web of Science ®Google Scholar
• Rescigno M, Urbano M, Valzasina B et al. Dendritic cells express tight junction proteins and penetrate gut epithelial monolayers to sample bacteria. Nat. Immunol.2(4), 361–367 (2001).
   PubMed Web of Science ®Google Scholar
• Kelsall BL, Strober W. Distinct populations of dendritic cells are present in the subepithelial dome and T cell regions of the murine Peyer’s patch. J. Exp. Med.183(1), 237–247 (1996).
   PubMed Web of Science ®Google Scholar
• Niess JH, Brand S, Gu X et al. CX3CR1-mediated dendritic cell access to the intestinal lumen and bacterial clearance. Science307(5707), 254–258 (2005).
   PubMed Web of Science ®Google Scholar
• Kraehenbuhl JP, Corbett M. Immunology. Keeping the gut microflora at bay. Science203(5664), 1624–1625 (2004).
   Google Scholar
• Macpherson AJ, Uhr T. Induction of protective IgA by intestinal dendritic cells carrying commensal bacteria. Science303(5664), 1662–1665 (2004).
   PubMed Web of Science ®Google Scholar
• Tezuka H, Abe Y, Iwata M et al. Regulation of IgA production by naturally occurring TNF/iNOS-producing dendritic cells. Nature448(7156), 929–933 (2007).
   PubMed Web of Science ®Google Scholar
• Ngan J, Kind LS. Suppressor T cells for IgE and IgG in Peyer’s patches of mice made tolerant by the oral administration of ovalbumin. J. Immunol.120(3), 861–865 (1978).
   PubMed Web of Science ®Google Scholar
• Johansson-Lindbom B, Agace WW. Vitamin A helps gut T cells find their way in the dark. Nat. Med.10(12), 1300–1301 (2004).
   PubMed Web of Science ®Google Scholar
• Johansson-Lindbom B, Agace WW. Generation of gut-homing T cells and their localization to the small intestinal mucosa. Immunol. Rev.215, 226–242 (2007).
   PubMed Web of Science ®Google Scholar
• Johansson-Lindbom B, Svensson M, Pabst O et al. Functional specialization of gut CD103+ dendritic cells in the regulation of tissue-selective T cell homing. J. Exp. Med.202(8), 1063–1073 (2005).
   PubMed Web of Science ®Google Scholar
• Johansson-Lindbom B, Svensson M, Wurbel MA, Malissen B, Marquez G, Agace W. Selective generation of gut tropic T cells in gut-associated lymphoid tissue (GALT): requirement for GALT dendritic cells and adjuvant. J. Exp. Med.198(6), 963–969 (2003).
   PubMed Web of Science ®Google Scholar
• Siewert C, Menning A, Dudda J et al. Induction of organ-selective CD4+ regulatory T cell homing. Eur. J. Immunol.37(4), 978–89 (2007).
   PubMed Web of Science ®Google Scholar
• Sun CM, Hall JA, Blank RB et al. Small intestine lamina propria dendritic cells promote de novo generation of Foxp3 T reg cells via retinoic acid. J. Exp. Med.204(8), 1775–1785 (2007).
   PubMed Web of Science ®Google Scholar
• von Boehmer H. Oral tolerance: is it all retinoic acid? J. Exp. Med.204(8), 1737–1739 (2007).
   PubMed Web of Science ®Google Scholar
• Denning TL, Wang YC, Patel SR, Williams IR, Pulendran B. Lamina propria macrophages and dendritic cells differentially induce regulatory and interleukin 17-producing T cell responses. Nat. Immunol.8(10), 1086–1094 (2007).
   PubMed Web of Science ®Google Scholar
• Holmgren J, Czerkinsky C, Eriksson K, Mharandi A. Mucosal immunisation and adjuvants: a brief overview of recent advances and challenges. Vaccine21(Suppl. 2), S89–S95 (2003).
   PubMed Web of Science ®Google Scholar
• Schoen C, Stritzker J, Goebel W, Pilgrim S. Bacteria as DNA vaccine carriers for genetic immunization. Int. J. Med. Microbiol.294(5), 319–335 (2004).
   PubMed Web of Science ®Google Scholar
• Vajdy M, Srivastava I, Polo J, Donnelly J, O’Hagan D, Singh M. Mucosal adjuvants and delivery systems for protein-, DNA- and RNA-based vaccines. Immunol. Cell Biol.82(6), 617–627 (2004).
   PubMed Web of Science ®Google Scholar
• Mohamadzadeh M, Chen L, Schmaljohn AL. How Ebola and Marburg viruses battle the immune system. Nat. Rev. Immunol.7(7), 556–567 (2007).
   PubMed Web of Science ®Google Scholar
• Guerrero RA, Ball JM, Krater SS, Pacheco SE, Clements JD, Estes MK. Recombinant Norwalk virus-like particles administered intranasally to mice induce systemic and mucosal (fecal and vaginal) immune responses. J. Virol.75(20), 713–722 (2001).
   Google Scholar
• Niikura M, Takamura S, Kim G et al. Chimeric recombinant hepatitis E virus-like particles as an oral vaccine vehicle presenting foreign epitopes. Virology293(2), 273–280 (2002).
   PubMed Web of Science ®Google Scholar
• Shi W, Liu J, Huang Y, Qiao L. Papillomavirus pseudovirus: a novel vaccine to induce mucosal and systemic cytotoxic T-lymphocyte responses. J. Virol.75(21), 10139–10148 (2001).
   PubMed Web of Science ®Google Scholar
• Warfield KL, Swenson DL, Demmin G, Bavari S. Filovirus-like particles as vaccines and discovery tools. Expert Rev. Vaccines4(3), 429–440 (2005).
   PubMed Web of Science ®Google Scholar
• Reed DS, Mohamadzadeh M. Status and challenges of filovirus vaccines. Vaccine25(11), 1923–1934 (2007).
   PubMed Web of Science ®Google Scholar
• Holmgren J, Harandi AM, Czerkinsky C. Mucosal adjuvants and anti-infection and anti-immunopathology vaccines based on cholera toxin, cholera toxin B subunit and CpG DNA. Expert Rev. Vaccines2(2), 205–217 (2003).
   PubMedGoogle Scholar
• Plant A, Williams NA. Modulation of the immune response by the cholera-like enterotoxins. Curr. Top. Med. Chem.4(5), 509–519 (2004).
   PubMed Web of Science ®Google Scholar
• Elson CO, Dertzbaugh MT (Eds). Mucosal Adjuvants. New York Academic Press, NY, USA (1999).
   Google Scholar
• Dal Bello F, Hertel C. Oral cavity as natural reservoir for intestinal lactobacilli. Syst. Appl. Microbiol.29(1), 69–76 (2006).
   PubMed Web of Science ®Google Scholar
• FAO/WHO. Report of a joint FAO/WHO expert consultation on evaluation of health and nutritional properties of probiotics in food including powder milk with live lactic acid bacteria. Presented at: Health and Nutritional Properties of Probiotics in Food Including Powder Milk with Live Lactic Acid Bacteria. Cordoba, Argentina, 1–4 October 2001.
   Google Scholar
• Ouwehand AC, Salminen S, Isolauri E. Probiotics: an overview of beneficial effects. Antonie Van Leeuwenhoek82(1–4), 279–289 (2002).
   PubMed Web of Science ®Google Scholar
• Roberts M, Chatfield S, Pickard D, Li J, Bacon A. Comparison of abilities of Salmonella enterica serovar typhimurium aroA aroD and aroA htrA mutants to act as live vectors. Infect. Immun.68(10), 6041–6043 (2000).
   PubMed Web of Science ®Google Scholar
• Stevenson A, Roberts M. Use of Bordetella bronchiseptica and Bordetella pertussis as live vaccines and vectors for heterologous antigens. FEMS Immunol. Med. Microbiol.37(2–3), 121–128 (2003).
   PubMedGoogle Scholar
• Saklani-Jusforgues H, Fontan E, Soussi N, Milon G, Goossens PL. Enteral immunization with attenuated recombinant Listeria monocytogenes as a live vaccine vector: organ-dependent dynamics of CD4 T lymphocytes reactive to a Leishmania major tracer epitope. Infect. Immun.71(3), 1083–1090 (2003).
   PubMed Web of Science ®Google Scholar
• Pouwels PH, Leer RJ, Shaw M et al. Lactic acid bacteria as antigen delivery vehicles for oral immunization purposes. Int. J. Food Microbiol.41(2), 155–167 (1998).
   PubMed Web of Science ®Google Scholar
• Wells JM, Robinson K, Chamberlain LM, Schofield KM, Le Page RW. Lactic acid bacteria as vaccine delivery vehicles. Antonie Van Leeuwenhoek70(2–4), 317–330 (1996).
   PubMed Web of Science ®Google Scholar
• Hanniffy S, Wiedermann U, Repa A et al. Potential and opportunities for use of recombinant lactic acid bacteria in human health. Adv. Appl. Microbiol.56, 1–64 (2004).
   PubMed Web of Science ®Google Scholar
• Robinson K, Chamberlain LM, Schofield KM, Wells JM, Le Page RW. Oral vaccination of mice against tetanus with recombinant Lactococcus lactis. Nat. Biotechnol.15(7), 653–657 (1997).
   PubMed Web of Science ®Google Scholar
• Grangette C, Muller-Alouf H, Geoffroy M, Goudercourt D, Turneer M, Mercenier A. Protection against tetanus toxin after intragastric administration of two recombinant lactic acid bacteria: impact of strain viability and in vivo persistence. Vaccine20(27–28), 3304–3309 (2002).
   PubMed Web of Science ®Google Scholar
• Maassen CB, Laman JD, den Bak-Glashouwer MJ et al. Instruments for oral disease-intervention strategies: recombinant Lactobacillus casei expressing tetanus toxin fragment C for vaccination or myelin proteins for oral tolerance induction in multiple sclerosis. Vaccine17(17), 2117–2128 (1999).
   PubMed Web of Science ®Google Scholar
• Plant LJ, Conway PL. Adjuvant properties and colonization potential of adhering and non-adhering Lactobacillus spp following oral administration to mice. FEMS Immunol. Med. Microbiol.34(2), 105–111 (2002).
   PubMedGoogle Scholar
• Mercenier A, Pavan S, Pot B. Probiotics as biotherapeutic agents: present knowledge and future prospects. Curr. Pharm. Des.9(2), 175–191 (2003).
   PubMed Web of Science ®Google Scholar
• Miettinen M, Vuopio-Varkila J, Varkila K. Production of human tumor necrosis factor a, interleukin-6, and interleukin-10 is induced by lactic acid bacteria. Infect. Immun.64(12), 5403–5405 (1996).
   PubMed Web of Science ®Google Scholar
• Marin ML, Tejada-Simon MV, Lee JH, Murtha J, Ustunol Z, Pestka JJ. Stimulation of cytokine production in clonal macrophage and T-cell models by Streptococcus thermophilus: comparison with Bifidobacterium spp. and Lactobacillus bulgaricus. J. Food Prot.61(7), 859–864 (1998).
   PubMed Web of Science ®Google Scholar
• Christensen HR, Frokiaer H, Pestka JJ. Lactobacilli differentially modulate expression of cytokines and maturation surface markers in murine dendritic cells. J. Immunol.168(1), 171–178 (2002).
   PubMed Web of Science ®Google Scholar
• Maassen CB, van Holten-Neelen C, Balk F et al. Strain-dependent induction of cytokine profiles in the gut by orally administered Lactobacillus strains. Vaccine18(23), 2613–2623 (2000).
   PubMed Web of Science ®Google Scholar
• Link-Amster H, Rochat F, Saudan KY, Mignot O, Aeschlimann JM. Modulation of a specific humoral immune response and changes in intestinal flora mediated through fermented milk intake. FEMS Immunol. Med. Microbiol.10(1), 55–63 (1994).
   PubMed Web of Science ®Google Scholar
• Kaila M, Isolauri E, Soppi E, Virtanen E, Laine S, Arvilommi H. Enhancement of the circulating antibody secreting cell response in human diarrhea by a human Lactobacillus strain. Pediatr. Res.32(2), 141–144 (1992).
   PubMed Web of Science ®Google Scholar
• Mohamadzadeh M, Olson S, Kalina WV et al.Lactobacilli activate human dendritic cells that skew T cells toward T helper 1 polarization. Proc. Natl Acad. Sci. USA102(8), 2880–2885 (2005).
   PubMed Web of Science ®Google Scholar
• Kalina WV, Mohamadzadeh M. Lactobacilli as natural enhancer of cellular immune response. Discovery Medicine5(26), 199–203 (2005).
   PubMedGoogle Scholar
• Curiel TJ, Morris C, Brumlik M et al. Peptides identified through phage display direct immunogenic antigen to dendritic cells. J. Immunol.172(12), 7425–7431 (2004).
   PubMed Web of Science ®Google Scholar
• Steidler L, Neirynck S, Huyghebaert N et al. Biological containment of genetically modified Lactococcus lactis for intestinal delivery of human interleukin 10. Nat. Biotechnol.21(7), 785–789 (2003).
   PubMed Web of Science ®Google Scholar
• Braat H, Rottiers P, Hommes DW et al. A Phase I trial with transgenic bacteria expressing interleukin-10 in Crohn’s disease. Clin. Gastroenterol. Hepatol.4(6), 754–759 (2006).
   PubMed Web of Science ®Google Scholar
• Bermudez-Humaran LG, Cortes-Perez NG, Lefevre F et al. A novel mucosal vaccine based on live lactococci expressing E7 antigen and IL-12 induces systemic and mucosal immune responses and protects mice against human papillomavirus type 16-induced tumors. J. Immunol.175(11), 7297–7302 (2005).
   PubMed Web of Science ®Google Scholar
• Zegers ND, Kluter E, van Der Stap H et al. Expression of the protective antigen of Bacillus anthracis by Lactobacillus casei: towards the development of an oral vaccine against anthrax. J. Appl. Microbiol.7(2), 309–314 (1999).
   Google Scholar
• Ho PS, Kwang J, Lee YK. Intragastric administration of Lactobacillus casei expressing transmissible gastroentritis coronavirus spike glycoprotein induced specific antibody production. Vaccine23(11), 335–342 (2005).
   Google Scholar
• Poo H, Pyo HM, Lee TY et al. Oral administration of human papillomavirus type 16 E7 displayed on Lactobacillus casei induces E7-specific antitumor effects in C57/BL6 mice. Int. J. Cancer119(7), 1702–1709 (2006).
   PubMed Web of Science ®Google Scholar
• Kajikawa A, Satoh E, Leer RJ, Yamamoto S, Igimi S. Intragastric immunization with recombinant Lactobacillus casei expressing flagellar antigen confers antibody-independent protective immunity against Salmonella enterica serovar Enteritidis. Vaccine25(18), 3599–3605 (2007).
   PubMed Web of Science ®Google Scholar
• Oliveira ML, Monedero V, Miyaji EN, Leite LC, Lee Ho P, Perez-Martinez G. Expression of Streptococcus pneumoniae antigens, PsaA (pneumococcal surface antigen A) and PspA (pneumococcal surface protein A) by Lactobacillus casei. FEMS Microbiol. Lett.227(1), 25–31 (2003).
   PubMed Web of Science ®Google Scholar
• Lee JS, Poo H, Han DP et al. Mucosal immunization with surface-displayed severe acute respiratory syndrome coronavirus spike protein on Lactobacillus casei induces neutralizing antibodies in mice. J. Virol.80(8), 4079–4087 (2006).
   PubMed Web of Science ®Google Scholar
• Oliveira ML, Areas AP, Campos IB et al. Induction of systemic and mucosal immune response and decrease in Streptococcus pneumoniae colonization by nasal inoculation of mice with recombinant lactic acid bacteria expressing pneumococcal surface antigen A. Microbes Infect.8(4), 1016–1024 (2006).
   PubMed Web of Science ®Google Scholar
• Corthesy B, Boris S, Isler P, Grangette C, Mercenier A. Oral immunization of mice with lactic acid bacteria producing Helicobacter pylori urease B subunit partially protects against challenge with Helicobacter felis. J. Infect. Dis.192(8), 1441–1449 (2005).
   PubMed Web of Science ®Google Scholar
• Cheun HI, Kawamoto K, Hiramatsu M et al. Protective immunity of SpaA-antigen producing Lactococcus lactis against Erysipelothrix rhusiopathiae infection. J. Appl. Microbiol.96(6), 1347–1353 (2004).
   PubMed Web of Science ®Google Scholar
• Lee MH, Roussel Y, Wilks M, Tabaqchali S. Expression of Helicobacter pylori urease subunit B gene in Lactococcus lactis MG1363 and its use as a vaccine delivery system against H. pylori infection in mice. Vaccine19(28–29), 3927–3935 (2001).
   PubMed Web of Science ®Google Scholar
• Xin KQ, Hoshino Y, Toda Y et al. Immunogenicity and protective efficacy of orally administered recombinant Lactococcus lactis expressing surface-bound HIV Env. Blood102(1), 223–228 (2003).
   PubMed Web of Science ®Google Scholar
• Ramasamy R, Yasawardena S, Zomer A, Venema G, Kok J, Leenhouts K. Immunogenicity of a malaria parasite antigen displayed by Lactococcus lactis in oral immunisations. Vaccine24(18), 3900–3908 (2006).
   PubMed Web of Science ®Google Scholar
• Perez CA, Eichwald C, Burrone O, Mendoza D. Rotavirus vp7 antigen produced by Lactococcus lactis induces neutralizing antibodies in mice. J. Appl. Microbiol.99(5), 1158–1164 (2005).
   PubMed Web of Science ®Google Scholar